Osaka Organic Chemical Industry Ltd.TSE: 4187

Consolidated Financial Results for the Three Months Ended February 28, 2025(April 11, 2025 312 KB)

· Issued by Osaka Organic Chemical Industry Ltd.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

Consolidated Financial Results

for the Three Months Ended February 28, 2025

[Japanese GAAP]

April 11, 2025

Company name: OSAKA ORGANIC CHEMICAL INDUSTRY LTD.

Listing: Tokyo Stock Exchange

Securities code: 4187

URL: https://www.ooc.co.jp/

Representative: Masayuki Ando

Representative Director and CEO

Inquiries: Soichi Honda

Director, Corporate Officer, General Manager of Administration

Division

Telephone: +81-6-6264-5071

Scheduled date to commence dividend payments: -

Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: None

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated Financial Results for the Three Months Ended February 28, 2025 (December 1, 2024 to February 28, 2025)

(1) Consolidated Operating Results

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Three months ended

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

February 28, 2025

8,516

20.5

1,365

135.2

1,480

131.3

1,035

71.6

February 29, 2024

7,066

2.8

580

(42.3)

640

(38.4)

603

(17.0)

(Note) Comprehensive income:

Three months ended February 28, 2025:

¥

835 million

[

(28.3) %]

Three months ended February 29, 2024:

¥

1,164 million

[

24.4%]

Basic earnings

Diluted earnings per

per share

share

Three months ended

Yen

Yen

February 28, 2025

49.96

-

February 29, 2024

28.47

-

(2) Consolidated Financial Position

Total assets

Net assets

Capital adequacy ratio

As of

Millions of yen

Millions of yen

%

February 28, 2025

54,467

44,003

79.4

November 30, 2024

59,964

46,139

75.8

(Reference) Equity: As of

February 28, 2025:

¥

43,273 million

As of

November 30, 2024:

¥

45,435 million

2. Dividends

Annual dividends

1st

2nd

3rd

Year-end

Total

quarter-end

quarter-end

quarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended November 30, 2024

-

32.00

-

34.00

66.00

Fiscal year ending November 30, 2025

-

Fiscal year ending November 30, 2025

34.00

-

34.00

68.00

(Forecast)

(Note) Revision to the forecast for dividends announced most recently:

None

(Note) Breakdown of the 1st quarter dividend for the fiscal year ending November 30, 2025 :

Commemorative dividend

-

yen

Special dividend

-

yen

3. Consolidated Financial Results Forecast for the Fiscal Year Ending November 30, 2025(December 1, 2024 to November 30, 2025) (Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable

Basic earnings

to owners of parent

per share

Millions of

%

Millions of

%

Millions of

%

Millions of

%

Yen

yen

yen

yen

yen

Six months ending May

16,800

9.5

2,500

34.4

2,600

30.7

1,700

(15.8)

81.00

31, 2025

Full year

34,000

4.0

5,000

8.5

5,200

9.4

3,500

(13.5)

165.50

(Note) Revision to the financial results forecast announced most recently:

None

* Notes:

(1) Significant changes in the scope of consolidation during the period:

Yes

Newly included:

1

(Company name: OSAKA ORGANIC CHEMICAL INDUSTRY KOREA LTD.

)

Excluded:

-

(Company name: -

)

  1. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None
  2. Changes in accounting policies, changes in accounting estimates, and restatement
    1. Changes in accounting policies due to revisions to accounting standards and other regulations: Yes
    2. Changes in accounting policies due to other reasons: None
    3. Changes in accounting estimates: None
    4. Restatement: None

(Note) Please refer to "2. Quarterly Consolidated Financial Statements and Notes, (3) Notes to Quarterly Consolidated Financial Statements, Changes in Accounting Policies" on page 8 of the attached materials for details.

  1. Number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury shares):

February 28, 2025:

22,410,038

shares

November 30, 2024:

22,410,038

shares

2) Number of treasury shares at the end of the period:

February 28, 2025:

2,083,311

shares

November 30, 2024:

1,283,303

shares

3) Average number of shares outstanding during the period:

Three months ended February 28, 2025:

20,726,729

shares

Three months ended February 29, 2024:

21,195,658

shares

  • Review of the Japanese-language originals of the attached quarterly consolidated financial statements by certified public accountants or an audit firm: None
  • Proper use of earnings forecasts, and other special matters
    The forward-looking statements in this document, including forecasts of financial results, are based on information currently available to the Company and are subject to a number of uncertainties. Accordingly, actual results may differ from the forecasts due to changes in business conditions and other factors. Please refer to "Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements" on page 3 of the attached materials for matters related to forecasts of financial results.

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

  • Contents of Attachments

1. Overview of Results of Operations

2

(1)

Results of Operations for the Period under Review

2

(2)

Financial Position for the Period under Review

3

(3)

Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements

3

2. Quarterly Consolidated Financial Statements and Notes

4

(1)

Quarterly Consolidated Balance Sheets

4

(2)

Quarterly Consolidated Statements of Income and Comprehensive Income

6

(3)

Notes to Quarterly Consolidated Financial Statements

8

Going Concern Assumption

8

Notes to Quarterly Consolidated Statements of Cash Flows

8

Significant Changes in Shareholders' Equity

8

Changes in Scope of Consolidation or Scope of Application of Equity Method

8

Changes in Accounting Policies

8

Segment and Other Information

9

Significant Subsequent Events

10

1

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

1. Overview of Results of Operations

(1) Results of Operations for the Period under Review

During the three months ended February 28, 2025, the Japanese economy continued to recover moderately on the back of personal consumption and capital investment picking up. However, the outlook remains uncertain due to a risk of downward pressure on the Japanese economy stemming from price increases, trade and other policy trends in the U.S., and conditions surrounding the Middle East region.

Under these circumstances, we launched a new medium-term management plan Progress & Development 2030 (P&D 2030) for the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Based on our Group management philosophy, P&D 2030 has set a management vision of "providing value to the global market as a leading company in specialty acrylic acid esters." Under this vision, we will promote sustainable management that takes ESG into account, aiming to increase corporate value and achieve sustainable growth.

In the Chemical Products Business, we worked to improve profit ratios mainly by integrating and closing products and improving production efficiency, and focused on expanding sales of environmentally friendly products, such as those derived from biomass. In the Electronics Materials Business, the Group worked to accelerate the development of cutting-edge semiconductor materials and to develop new applications for photoresist materials. In the Specialty Chemicals Business, the Group worked to strengthen the overseas expansion of cosmetic raw materials and expand sales of high-purity special solvents. In the current fiscal year, following a subsidiary in South Korea established last year, we are planning to establish a sales base in North America, and we will work to strengthen our overseas sales system by acquiring new customers and cultivating new markets.

As a result, for the three months ended February 28, 2025, net sales were 8,516 million yen (up 20.5% year on year), operating profit was 1,365 million yen (up 135.2% year on year), ordinary profit was 1,480 million yen (up 131.3% year on year), and profit attributable to owners of parent was 1,035 million yen (up 71.6% year on year).

1)Business results by segment are explained below (excluding inter-segment transactions). Chemical Products Business

In the Chemical Products Business, sales of automotive coatings were flat in the acrylic acid ester group, but sales for display adhesives increased significantly, along with increased sales for UV inkjet inks. In the methacrylate ester group, sales were weak. As a result, net sales were 3,316 million yen (up 22.7% year on year) and segment profit was 527 million yen (up 102.4% year on year).

  1. Electronic Materials Business

In the Electronic Materials Business, sales of raw materials for cutting-edge EUV resists decreased in the semiconductor materials group, but sales of raw materials for ArF resists, which are the Company's mainstay, recovered, and Group-wide sales increased. In the display materials group, sales for insulating films for touch panels were strong, and sales for the group as a whole increased. In addition, sales of other groups were flat. As a result, net sales were 3,724 million yen (up 20.2% year on year) and segment profit was 530 million yen (up 202.6% year on year).

  1. Specialty Chemicals Business

In the Specialty Chemicals Business, sales were flat in the cosmetics materials group. In the functional materials group, sales remained solid. Sales of high-purity specialty solvents at subsidiaries remained strong. As a result, net sales were 1,476 million yen (up 16.8% year on year) and segment profit was 315 million yen (up 138.1% year on year).

2

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

(2) Financial Position for the Period under Review

Total assets at the end of the first quarter of the current fiscal year decreased by 5,497 million yen from the end of the previous fiscal year to 54,467 million yen. This was mainly attributable to a decrease of 2,921 million yen in cash and deposits, a decrease of 1,725 million yen in notes and accounts receivable-trade and contract assets, mainly due to the last day of the previous fiscal year being a holiday for financial institutions, a decrease of 221 million yen in finished goods, and a decrease of 281 million yen investment securities.

Liabilities at the end of the first quarter of the current fiscal year decreased by 3,360 million yen from the end of the previous fiscal year to 10,463 million yen. This was mainly due to a decrease of 1,714 million yen in notes and accounts payable - trade, mainly due to the last day of the previous fiscal year being a holiday for financial institutions, a decrease of 523 million yen in accounts payable - other, and a decrease of 407 million yen in income taxes payable.

Net assets at the end of the first quarter of the current fiscal year decreased by 2,136 million yen from the end of the previous fiscal year to 44,003 million yen. This was mainly due to an increase of 309 million yen in retained earnings, an increase of 2,224 million yen in treasury shares, and a decrease of 211 million yen in valuation difference on available-for-sale securities.

  1. Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements The consolidated financial results forecast announced on January 9, 2025, remain unchanged.

3

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

2. Quarterly Consolidated Financial Statements and Notes

(1) Quarterly Consolidated Balance Sheets

(Thousands of yen)

As of November 30, 2024

As of February 28, 2025

Assets

Current assets

Cash and deposits

13,047,614

10,126,298

Notes and accounts receivable - trade, and contract

11,252,037

9,526,371

assets

Electronically recorded monetary claims -

374,384

394,629

operating

Finished goods

4,799,006

4,577,633

Work in process

2,070,025

2,067,873

Raw materials and supplies

1,989,293

1,982,533

Other

773,069

777,723

Allowance for doubtful accounts

(18,415)

(14,176)

Total current assets

34,287,015

29,438,887

Non-current assets

Property, plant and equipment

Buildings and structures, net

8,327,194

8,183,923

Machinery, equipment and vehicles, net

7,530,545

7,319,999

Land

2,172,476

2,172,476

Construction in progress

94,679

38,330

Other, net

290,291

317,537

Total property, plant and equipment

18,415,187

18,032,266

Intangible assets

Goodwill

23,333

18,333

Other

50,538

46,700

Total intangible assets

73,871

65,033

Investments and other assets

Investment securities

6,294,854

6,013,701

Retirement benefit asset

758,144

766,761

Deferred tax assets

1,927

1,496

Other

133,712

148,955

Total investments and other assets

7,188,638

6,930,915

Total non-current assets

25,677,697

25,028,215

Total assets

59,964,713

54,467,103

4

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

(Thousands of yen)

As of November 30, 2024

As of February 28, 2025

Liabilities

Current liabilities

Notes and accounts payable - trade

5,924,864

4,210,272

Current portion of long-term borrowings

2,188,610

2,104,453

Accounts payable - other

1,524,265

1,000,978

Income taxes payable

895,161

487,951

Provision for bonuses

-

263,716

Provision for bonuses for directors (and other

42,210

8,805

officers)

Other

1,154,766

600,754

Total current liabilities

11,729,879

8,676,931

Non-current liabilities

Long-term borrowings

1,337,923

1,200,459

Deferred tax liabilities

634,911

472,849

Provision for share awards for directors (and other

35,086

-

officers)

Other

86,937

113,522

Total non-current liabilities

2,094,858

1,786,831

Total liabilities

13,824,737

10,463,763

Net assets

Shareholders' equity

Share capital

3,600,295

3,600,295

Capital surplus

3,513,436

3,513,443

Retained earnings

38,727,951

39,037,663

Treasury shares

(3,129,535)

(5,353,564)

Total shareholders' equity

42,712,148

40,797,837

Accumulated other comprehensive income

Valuation difference on available-for-sale

2,344,090

2,132,130

securities

Foreign currency translation adjustment

132,235

99,458

Remeasurements of defined benefit plans

246,812

244,313

Total accumulated other comprehensive income

2,723,138

2,475,902

Non-controlling interests

704,689

729,599

Total net assets

46,139,976

44,003,339

Total liabilities and net assets

59,964,713

54,467,103

5

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

  1. Quarterly Consolidated Statements of Income and Comprehensive Income
    Quarterly Consolidated Statements of Income (For the three months)

(Thousands of yen)

For the three months

For the three months

ended February 29, 2024

ended February 28, 2025

Net sales

7,066,021

8,516,926

Cost of sales

5,282,984

5,846,560

Gross profit

1,783,036

2,670,366

Selling, general and administrative expenses

1,202,420

1,304,495

Operating profit

580,615

1,365,870

Non-operating income

Interest income

601

2,771

Dividend income

33,947

36,842

Foreign exchange gains

17,549

-

Insurance claim income

-

97,183

Other

11,105

28,683

Total non-operating income

63,203

165,480

Non-operating expenses

Interest expenses

2,314

2,406

Foreign exchange losses

-

45,193

Commission for purchase of treasury shares

602

2,400

Loss on investments in investment partnerships

591

506

Other

-

0

Total non-operating expenses

3,508

50,507

Ordinary profit

640,311

1,480,843

Extraordinary income

Gain on sale of investment securities

273,751

-

Total extraordinary income

273,751

-

Extraordinary losses

Loss on retirement of non-current assets

102

199

Total extraordinary losses

102

199

Profit before income taxes

913,960

1,480,644

Income taxes - current

409,192

466,937

Income taxes - deferred

(116,318)

(68,048)

Total income taxes

292,873

398,888

Profit

621,086

1,081,755

Profit attributable to non-controlling interests

17,675

46,306

Profit attributable to owners of parent

603,410

1,035,449

6

OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (4187) Financial Results for the First Quarter of FY11/25

Quarterly Consolidated Statements of Comprehensive Income (For the three months)

(Thousands of yen)

For the three months

For the three months

ended February 29, 2024

ended February 28, 2025

Profit

621,086

1,081,755

Other comprehensive income

Valuation difference on available-for-sale securities

526,368

(211,286)

Foreign currency translation adjustment

14,415

(32,776)

Remeasurements of defined benefit plans, net of tax

2,224

(2,559)

Total other comprehensive income

543,008

(246,623)

Comprehensive income

1,164,094

835,132

Comprehensive income attributable to

Comprehensive income attributable to owners of

1,145,212

788,214

parent

Comprehensive income attributable to non-controlling

18,881

46,917

interests

7

Company analysis